Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 4 Open-market sale U.S. President-Pharma Business sold 3,251 shares at $25.02 ($81,340)
  2. 4 Open-market sale U.S. President-Pharma Business sold 3,251 shares at $26.63 ($86,574)
  3. 4 Grant or award Director acquired 1,245 shares (grant or award)
  4. 4 Grant or award Director acquired 249 shares (grant or award)
  5. 4 Grant or award Director acquired 1,380 shares (grant or award)
  6. 4 Grant or award Director acquired 1,109 shares (grant or award)
  7. 4 Grant or award Director acquired 1,109 shares (grant or award)
  8. 4 Grant or award Director acquired 1,109 shares (grant or award)
  9. 4 Shares withheld for taxes CEO, Pharma Business gave up 3,461 shares (to pay taxes)
  10. 4 Open-market buy Director bought 60,000 shares at an average $24.23 ($1,453,524)
  11. 4 Grant or award SVP, Controller and CAO acquired 1,246 shares (grant or award)
  12. 4 Shares withheld for taxes U.S. President-Pharma Business gave up 283 shares (to pay taxes)
  13. 4 Grant or award Director acquired 246 shares (grant or award)
  14. 4 Grant or award Director acquired 1,368 shares (grant or award)
  15. 4 Grant or award Director acquired 1,099 shares (grant or award)
  16. 4 Grant or award Director acquired 1,099 shares (grant or award)
  17. 4 Grant or award Director acquired 1,099 shares (grant or award)
  18. 4 Grant or award Director acquired 1,234 shares (grant or award)
  19. 4 Shares withheld for taxes CHAIRMAN & CEO gave up 8,559 shares (to pay taxes)
  20. 4 Grant or award President, Salix acquired 9,026 shares (grant or award)

Page 13 of 61 · 1,214 filings